CBER's strategic plan: response from the physician/medical community.
Parkman
P D
PD
D001688:Biological Products; D003257:Consumer Product Safety; D017277:Drug Approval / Q000331:legislation & jurisprudence; D017598:Efficiency, Organizational; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
D001688:Biological Products